Chennai Location
Change Your City
  • Chennai City
  • Nungambakkam
  • Chetpet
  • Ayanavaram
  • Kilpauk
  • Tambaram
  • Mylapore
  • Chromepet
  • Nanganallur
  • Madipakkam
  • Chitlapakkam
Search

Product Added Successfully.Please click cart button to proceed

Uploaded Successfully

Thank you for choosing TimesMed Pharmacy

Our representatives will contact you as soon as possible. If you want to reach us immediately, please call 98 8455 5001

Adtrinib 200mg Tablet

ManufacturerAdley Formulations
Selected Pack Size: Bottle Of 30 Tablets
CompositionSorafenib (200mg)
Consume TypeORAL
In Stock
Prescription Required
Price: ₹ 2350
Inclusive of all taxes
Qty
Bottle Of 30 Tablets in 1 Qty

PRODUCT DETAILS

About Adtrinib 200mg Tablet

SORAFENIB belongs to the group of medicine called ‘anti-cancer’ that is primarily indicated in the treatment of kidney, liver, and thyroid cancer.  Kidney cancer is also known as renal cancer is a disease in which healthy cells of the kidney become malignant (cancerous), grow in an uncontrolled manner, and forms a tumor. Cancer of the liver is known as liver cancer. When cancer occurs in the liver, it destroys healthy cells of the liver and affects the ability of the liver to function normally. Thyroid cancer occurs when cells start multiplying in the thyroid gland and form a tumor. The tumor is a collection of abnormal cells.

SORAFENIB contains 'Sorafenib' that falls in the category of medicines known as 'kinase inhibitors'. It works by stopping the action of an abnormal protein that causes the multiplication of cancerous cells. In this way, it stops the spread of cancerous cells.

Uses of Adtrinib 200mg Tablet

 Cancer (kidney, liver, and thyroid)

Medicinal Benefits of Adtrinib 200mg Tablet

SORAFENIB is a ' tyrosine kinase inhibitor (TKI)', that stops the uncontrolled growth and spread of cancerous cells. SORAFENIB is effective in treating thyroid, liver, and kidney cancer. It acts by stopping the action of the abnormal protein that is responsible for the multiplication of cancerous cells. Whenever a new healthy cell is formed it undergoes a usual process of maturity. Cancerous cells form new cells more quickly so SORAFENIB targets cancerous cells and block the action of Tyrosine kinases enzymes (responsible for causing cancer). In this way, SORAFENIB stops the production, spread, and growth of cancerous cells in the body.

Directions for Use

SORAFENIB can be taken without food on an empty stomach at least one or two hours before taking a meal. The tablet form of SORAFENIB should be swallowed as a whole with an ample amount of water, do not chew or break the tablet. It is advised to go for a regular checkup of blood pressure. The tablet form of SORAFENIB should be swallowed as a whole with an ample amount of water, do not chew or break the tablet.

Side Effects of Adtrinib 200mg Tablet

  • Acne
  • Dry skin
  • Nausea
  • Vomiting
  • Diarrhea
  • Loss of appetite
  • Itching or skin rash

Similar Drugs

For informational purposes only. Consult a doctor before taking any medicines.

Mapsonib 200mg TabletAMPS Biotech Pvt Ltd
11850
Nexavar 200mg TabletBayer Zydus Pharma Pvt Ltd
146037.5
Shilfenib 200mg TabletShilpa Medicare Ltd
7560
Sorafenat 200mg TabletNatco Pharma Ltd
8880
Sorafina TabletArechar Healthcare
7560
2276.01
1985
Adtrinib 200mg TabletAdley Formulations
2350
View All Similar Drugs

In-Depth Precautions and Warning

Drug-Drug Interaction:

SORAFENIB may have interaction with anti-cancer medicine (Sorafenib and Paclitaxel), antibiotics (Neomycin), anti-seizure medicine (carbamazepine, phenytoin), an antacid  (Omeprazole).

Safety Advice

ALCOHOL

You are recommended to avoid alcohol consumption with SORAFENIB as it may increase the risk of side effects such as dizziness, drowsiness, or difficulty in concentrating.

 

PREGNANCY

SORAFENIB is restricted to use in pregnancy. A woman needs to have a negative pregnancy test before starting treatment with this medicine. It is better to use effective birth control methods to prevent pregnancy while taking this medicine or for at least 6 months after taking the last dose of SORAFENIB.

 

BREAST FEEDING

SORAFENIB should not be taken by breastfeeding mothers as it passes into breast milk and may cause a possible risk to the infant.

 

DRIVING

It is not known if SORAFENIB may affect your driving ability or not.

 

LIVER

SORAFENIB is safe to take by patients dealing with liver cancer as prescribed by their doctor. 

KIDNEY

SORAFENIB is safe to take by patients dealing with kidney cancer as prescribed by their doctor.

Post Your Health Queries

CONSULT SUPER SPECIALITY DOCTORS

Hi, I'm Doctor's assistant. How may I help?
{{su.Name}}
Forgot Password
Forgot Password
Search result for ram